Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

Conditions:   Inflammatory Bowel Diseases;   Hepatitis C Virus Infection Interventions:   Drug: Assess the effectiveness and safety of DAAs in patients with IBD.;   Drug: Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics.;   Other: Assessment of the impact of DAAs on the course of IBD. Sponsor:   Hospital Mutua de Terrassa Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials